Macrogen is a leading biotechnology company headquartered in Seoul, South Korea, focused on genomic analysis and precision medicine. Founded in 1997, the company has grown into a global player in genomics, providing sequencing and bioinformatics services to research institutions, pharmaceutical companies and healthcare providers worldwide.

The company operates at the intersection of biotechnology, healthcare and data science, leveraging next-generation sequencing (NGS), big data and artificial intelligence to enable personalised medicine. Macrogen’s mission is to predict, diagnose and treat diseases through genome-based insights, ultimately advancing preventive and precision healthcare.

Macrogen has established a strong global presence, serving tens of thousands of customers across more than 150 countries through a network of genome centres in Asia, Europe and the Americas. Its infrastructure supports large-scale genomic sequencing and data analysis, enabling both research and clinical applications.

The company provides services across the entire genomics value chain, from research sequencing and bioinformatics to clinical diagnostics and consumer genetic testing. By integrating genomic data with medical and lifestyle information, Macrogen aims to drive innovation in disease prediction and personalised healthcare delivery.

Key products and services

Genomic sequencing services

• Whole genome, whole exome and transcriptome sequencing
• Next-generation sequencing (NGS) and Sanger sequencing
• Custom sequencing and fragment analysis services

Bioinformatics and data analysis

• Genomic data processing and interpretation
• AI-driven analytics and big data integration
• Research-grade and clinical data insights

Multi-omics and advanced research services

• Single-cell multi-omics and spatial transcriptomics
• Epigenomics, metagenomics and proteomics analysis
• Microarray and gene expression profiling

Clinical diagnostics and precision medicine

• Genetic testing for disease risk and cancer diagnostics
• Personalised healthcare and wellness genomics
• Integration of genomic, clinical and lifestyle data

Gene synthesis and molecular biology services

• DNA/RNA oligo synthesis and peptide synthesis
• CRISPR gene editing tools and model development
• Cell and molecular biology support services

Biobank and research infrastructure

• Human biobank for sample storage and research
• Support for large-scale genomic research programmes
• Collaboration with academic and medical institutions

By combining advanced genomic sequencing technologies with big data analytics and artificial intelligence, Macrogen is driving the transition towards precision medicine and personalised healthcare. Its global infrastructure, broad service portfolio and strong expertise in genomics position the company as a key partner for research, clinical development and next-generation healthcare innovation.